A study evaluating effect of intraocular pressure reduction by use of Ganfort® on retinal ganglion cell in patients with early stages of primary open-angle glaucoma (POAG).
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Bimatoprost/timolol (Primary)
- Indications Open-angle glaucoma
- Focus Therapeutic Use
- 10 Jul 2017 New trial record